Two more for AtCor

By Kate McDonald
Monday, 08 December, 2008

Medical device company AtCor has signed two new supply agreements worth US$1.5 million for its reflected blood pressure measurement system SphygmoCor.

The new agreements cap an excellent six months for the Sydney company, with supply contracts signed in the period worth US$5.7 million.

The device is aimed at both clinical practice and clinical trials to understand drug efficacy and mechanisms of action.

The SphygmoCor system visibly identifies the effects of reflected blood pressure in the central aortic pressure wave, effects which cannot be detected with standard blood pressure monitoring.

Related News

Space conditions can lead to periodontitis, scientists say

Living in zero gravity can lead to periodontitis — a serious condition where the gums...

Personalised brain stimulation helps treat those with depression

By tailoring transcranial magnetic stimulation to each person's unique brain structure,...

Flavonoid-rich foods help to maintain good health

Flavonoids are found in plant foods like tea, blueberries, strawberries, oranges, apples, grapes,...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd